Back to Trades
Total Value
$626.5K
Filing Date
Jan 29, 2026
1 transactions
Trade Summary
On Jan 27, 2026, Brockmann Bobbi Jo, VP of Sales and Marketing, Director, reported $626.5K of IMMUCELL CORP /DE/ (ICCC) across 1 transactions. The filing covers company securities and reflects balanced net activity of $0. Reported prices ranged from $6.26. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- IMMUCELL CORP /DE/
- Ticker Symbol
- ICCC
- CIK
- 0000811641
Insider Information
- Role
- VP of Sales and Marketing, Director
- Location
- PORTLAND, ME
Filing Details
- Filing Date
- Jan 29, 2026
- Transaction Date
- Jan 27, 2026
- Accession Number
- 0001437749-26-002369
- Form Type
- 4
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jan 27, 2026 | ICCC derivative | 100,000 | $6.26 | Grant/Award | $626.5K |
Want live alerts when Brockmann Bobbi Jo trades again?
Download Insider Trades to track ICCC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Option grant made to Ms. Brockmann in connection with her employment as Vice President of Sales and Marketing. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as a nonqualified stock option. The stock option vests as follows: 33,333 shares becoming exercisable on each of January 27, 2027 and January 27, 2028 and 33,334 shares becoming exercisable on January 27, 2029.